# Antihistamine for Prevention of HTR After Blood Primed CPB

> **NCT07536152** · PHASE4 · RECRUITING · sponsor: **Kasr El Aini Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Blood Transfusion Associated Adverse Reactions

## Interventions

- **DRUG:** Antihestamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07536152
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2026-11
- **Final completion:** 2026-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07536152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07536152, "Antihistamine for Prevention of HTR After Blood Primed CPB". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07536152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*